Sponsor Dossier
Perrigo
Sponsor Dossier for Perrigo. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMCAL
- Brand: Broncho
- Brand: Bronchodual Cough
- Brand: EllaOne
- Brand: Herron
- Brand: KWAN
- Brand: LYCLEAR
- Brand: MEDIHEALTH
- Device (sponsor): Exudate-absorbent dressing, hydrophilic-gel
- Device (sponsor): Wound hydrogel dressing, non-sterile
About
Perrigo is an Australian Private Company with ABN 15141623403, registered in Western Australia and currently active.
Portfolio
Perrigo has 13 brands on the ARTG, of which 4 are indexable and 2 carry a Product Information document. 2 brands are PBS-listed, 2 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include AMCAL, Broncho, Bronchodual Cough, EllaOne, Herron, KWAN, LYCLEAR, MEDIHEALTH, NICOTINELL, NORLEVO, NORLEVO-1, PHARMACY CARE.
Therapeutic focus
— Psychiatry: 4 brands — Reproductive Health: 3 brands — Pain Management: 2 brands — Musculoskeletal: 1 brand — Dermatology: 1 brand — Complementary Medicine: 1 brand — Respiratory: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2017-07-01, across 2 brands with a PBAC outcome on record. The latest AusPAR is 2015-09-15, across 1 brand with an AusPAR on record.